Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Secretion of multi-protein migratory complex induced by Toxoplasma gondii infection in macrophages involves the uPA/uPAR activation system.

Schuindt SH, Oliveira BC, Pimentel PM, Resende TL, Retamal CA, DaMatta RA, Seipel D, Arnholdt AC.

Vet Parasitol. 2012 May 25;186(3-4):207-15. doi: 10.1016/j.vetpar.2011.11.035. Epub 2011 Nov 20.

2.

Toxoplasma gondii infection positively modulates the macrophages migratory molecular complex by increasing matrix metalloproteinases, CD44 and alpha v beta 3 integrin.

Seipel D, Oliveira BC, Resende TL, Schuindt SH, Pimentel PM, Kanashiro MM, Arnholdt AC.

Vet Parasitol. 2010 May 11;169(3-4):312-9. doi: 10.1016/j.vetpar.2009.12.042. Epub 2010 Jan 7.

PMID:
20080350
3.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
4.

Monocytes/macrophages infected with Toxoplasma gondii do not increase co-stimulatory molecules while maintaining their migratory ability.

Seipel D, Ribeiro-Gomes FL, Barcelos MW, Ramalho AV, Kanashiro MM, Kipnis TL, Arnholdt AC.

APMIS. 2009 Sep;117(9):672-80. doi: 10.1111/j.1600-0463.2009.02519.x.

PMID:
19703127
5.

Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion.

Bonavaud S, Charrière-Bertrand C, Rey C, Leibovitch MP, Pedersen N, Frisdal E, Planus E, Blasi F, Gherardi R, Barlovatz-Meimon G.

J Cell Sci. 1997 May;110 ( Pt 9):1083-9.

6.

Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.

Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.

Scand J Gastroenterol. 2005 Jul;40(7):783-93.

PMID:
16109653
7.

Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.

Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B.

Mol Hum Reprod. 2004 Sep;10(9):655-63. Epub 2004 Jul 8.

PMID:
15243126
8.

Macrophages of M1 phenotype have properties that influence lung cancer cell progression.

Hedbrant A, Wijkander J, Seidal T, Delbro D, Erlandsson A.

Tumour Biol. 2015 Nov;36(11):8715-25. doi: 10.1007/s13277-015-3630-9. Epub 2015 Jun 7.

PMID:
26050228
9.

Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.

Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.

Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1364-70.

PMID:
15790903
10.

Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9.

Bianchini F, D'Alessio S, Fibbi G, Del Rosso M, Calorini L.

Oncol Rep. 2006 Mar;15(3):709-14.

PMID:
16465434
11.

Reduced secretion and expression of gelatinase profile in Toxoplasma gondii-infected human monocytic cells.

Buache E, Garnotel R, Aubert D, Gillery P, Villena I.

Biochem Biophys Res Commun. 2007 Jul 27;359(2):298-303. Epub 2007 May 24.

PMID:
17540340
12.

Integrin alpha(v)beta(3), metalloproteinases, and sphingomyelinase-2 mediate urokinase mitogenic effect.

Maupas-Schwalm F, Bedel A, Augé N, Grazide MH, Mucher E, Thiers JC, Salvayre R, Nègre-Salvayre A.

Cell Signal. 2009 Dec;21(12):1925-34. doi: 10.1016/j.cellsig.2009.08.010. Epub 2009 Sep 6.

PMID:
19735728
13.

Expression and activation of proteases in co-cultures.

Paduch R, Kandefer-Szerszeń M.

Exp Toxicol Pathol. 2011 Jan;63(1-2):79-87. doi: 10.1016/j.etp.2009.09.011. Epub 2009 Oct 17.

PMID:
19836935
14.

Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.

He Y, Liu XD, Chen ZY, Zhu J, Xiong Y, Li K, Dong JH, Li X.

Clin Cancer Res. 2007 Jun 1;13(11):3115-24.

15.

Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.

Yoshizawa K, Nozaki S, Kitahara H, Kato K, Noguchi N, Kawashiri S, Yamamoto E.

Oncol Rep. 2011 Dec;26(6):1555-60. doi: 10.3892/or.2011.1419. Epub 2011 Aug 10.

PMID:
21833477
17.

Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.

Gupta R, Chetty C, Bhoopathi P, Lakka S, Mohanam S, Rao JS, Dinh DE.

Int J Oncol. 2011 Mar;38(3):733-44. doi: 10.3892/ijo.2010.883. Epub 2010 Dec 22.

PMID:
21181094
18.
19.

Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.

Kenichi M, Masanobu M, Takehiko K, Shoko T, Akira F, Katsushige A, Takashi H, Yoshiyuki O, Shigeru K.

J Lab Clin Med. 2004 Aug;144(2):69-77.

PMID:
15322501
20.

Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.

Olson D, Pöllänen J, Høyer-Hansen G, Rønne E, Sakaguchi K, Wun TC, Appella E, Danø K, Blasi F.

J Biol Chem. 1992 May 5;267(13):9129-33.

Supplemental Content

Support Center